RedHill Biopharma (RDHL) Posts Smaller Q1 Loss

June 23, 2022 7:03 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.03), $0.20 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities